Literature DB >> 6088647

Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

A A Weiss, E L Hewlett, G A Myers, S Falkow.   

Abstract

A wild-type strain of Bordetella pertussis and a series of transposon Tn5-induced mutants deficient in the production of various factors believed to play a role in pertussis (whooping cough) were tested for virulence in infant mice. The 50% lethal dose of the wild-type strain in these animals was 2 X 10(3) bacteria. A mutant deficient in the production of the filamentous hemagglutinin was almost as virulent as the wild type. Avirulent phase mutants (i.e., deficient in the production of all toxins), a pertussis-toxin mutant, and a double mutant deficient in both hemolysin and adenylate cyclase were severely impaired in the ability to cause pertussis. These data underscore the role of pertussis toxin in the disease and provide the first direct evidence that adenylate cyclase and hemolysin are important in the pathogenesis of the infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088647     DOI: 10.1093/infdis/150.2.219

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  100 in total

1.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.

Authors:  S Z Hausman; D L Burns
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.

Authors:  Trevor H Stenson; Alison A Weiss
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro.

Authors:  P A Spears; L M Temple; P E Orndorff
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

8.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes.

Authors:  C R Roy; J F Miller; S Falkow
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

10.  Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.

Authors:  Scott H Millen; David I Bernstein; Beverly Connelly; Joel I Ward; Swei-Ju Chang; Alison A Weiss
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.